VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
FHTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
FHTXFoghorn Therapeutics Inc.
$1.87$110M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksFHTXQuarterly Financials

Foghorn Therapeutics Inc. (FHTX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Foghorn Therapeutics Inc. (FHTX) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

FHTX Income Statement

Quarterly statement

FHTX Income Statement

Foghorn Therapeutics Inc. (FHTX) annual income statement — 8-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue16.07M3.27M9.25M8.15M7.56M5.95M2.86M7.81M6.89M5.05M5.77M17.48M5.6M5.31M4.18M6.63M4.49M3.92M713K41K
Revenue Growth %112.68%-45.11%223.77%4.42%9.71%17.86%-50.49%-55.33%23.02%-4.88%37.88%163.46%24.7%35.43%486.82%16080.49%1509.32%1270.63%184.06%-77.09%
Cost of Goods Sold0238K802K20M900K00000852K26.25M29.25M028.21M26.93M25.97M24.51M22.46M20.49M
COGS % of Revenue-7.29%8.67%245.33%11.91%-----14.77%150.19%522.38%-674.19%405.91%578.49%625.2%3150.49%49985.37%
Gross Profit16.07M3.03M8.45M-11.85M6.66M5.95M2.86M7.81M6.89M5.05M4.92M-8.77M-23.65M5.31M-24.02M-20.29M-21.48M-20.59M-21.75M-20.45M
Gross Margin %100%92.72%91.33%-145.33%88.09%100%100%100%100%100%85.23%-50.19%-422.38%100%-574.19%-305.91%-478.49%-525.2%-3050.49%-49885.37%
Gross Profit Growth %141.43%-49.11%195.69%-251.75%-3.35%17.86%-41.92%189%129.13%-4.88%120.47%56.77%-10.08%125.79%-10.46%0.78%-17%-11.65%-6871.15%-11526.26%
Operating Expenses24.88M24.6M28.04M6.65M27.75M28.86M26.86M31.66M33.52M33.24M30.38M8.31M8.4M38.63M7.86M7.96M7.7M7.22M6.33M5.81M
OpEx % of Revenue154.78%753.05%303.24%81.59%367.26%484.96%940.51%405.48%486.64%658.3%526.52%47.53%150.04%727.56%187.91%120.06%171.58%184.08%888.08%14165.85%
Selling, General & Admin6.35M6.58M6.8M6.65M6.86M7.24M6.35M6.97M7.33M7.71M7.02M8.31M8.4M8.64M7.86M7.96M7.7M7.22M6.33M5.81M
SG&A % of Revenue39.53%201.44%73.5%81.59%90.8%121.62%222.44%89.28%106.34%152.67%121.72%47.53%150.04%162.76%187.91%120.06%171.58%184.08%888.08%14165.85%
Research & Development18.52M18.26M22.95M20M20.89M21.63M20.51M24.69M23.8M25.53M23.35M26.25M29.25M29.98M28.21M26.93M25.97M24.51M22.46M20.49M
R&D % of Revenue115.25%558.89%248.15%245.33%276.46%363.34%718.07%316.2%345.48%505.62%404.8%150.19%522.38%564.8%674.19%405.91%578.49%625.2%3150.49%49985.37%
Other Operating Expenses0-238K-1000K-1000K00001000K00-1000K-1000K0-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-8.8M-21.57M-19.6M-18.5M-21.1M-22.91M-24M-23.85M-26.63M-28.19M-25.46M-17.08M-32.05M-33.32M-31.89M-28.26M-29.19M-27.8M-28.08M-26.26M
Operating Margin %-54.78%-660.33%-211.92%-226.92%-279.17%-384.96%-840.51%-305.48%-386.64%-558.3%-441.29%-97.73%-572.42%-627.56%-762.09%-425.97%-650.07%-709.29%-3938.57%-64051.22%
Operating Income Growth %58.26%5.85%18.37%22.43%20.78%18.73%5.71%-39.64%16.9%15.38%20.16%39.56%-9.81%-19.83%-13.55%-7.61%-25.48%-20.21%-35.15%-42.04%
EBITDA-8.57M-21.34M-18.79M-17.65M-20.25M-22.09M-23.24M-23.12M-25.84M-27.36M-24.61M-16.22M-31.17M-32.46M-31.04M-27.42M-28.37M-26.99M-27.27M-25.4M
EBITDA Margin %-53.35%-653.05%-203.24%-216.47%-267.91%-371.07%-813.87%-296.09%-375.16%-541.76%-426.52%-92.79%-556.78%-611.38%-741.83%-413.26%-631.83%-688.6%-3824.96%-61951.22%
EBITDA Growth %57.65%3.4%19.14%23.66%21.65%19.27%5.54%-42.56%17.11%15.71%20.72%40.85%-9.89%-20.25%-13.81%-7.94%-26.21%-20.73%-34.9%-39.3%
D&A (Non-Cash Add-back)230K238K802K852K851K827K761K733K791K835K852K864K876K859K848K843K819K811K810K861K
EBIT-7.19M-19.88M-21.66M-15.85M-17.94M-18.83M-19.5M-19.12M-24.23M-25.02M-22.12M-17.08M-32.05M-33.32M-31.89M-28.26M-29.19M-27.8M-28.08M-26.26M
Net Interest Income1.61M1.74M1.71M2.03M2.31M2.69M3.1M3.5M2.87M2.44M2.66M2.75M2.79M2.67M420K1.84M1.23M235K172K181K
Interest Income1.61M1.74M1.71M2.03M2.31M2.69M3.1M3.5M2.87M2.44M2.66M2.75M2.79M2.67M420K1.84M1.23M235K598K680K
Interest Expense000000000000000000426K499K
Other Income/Expense1.61M1.7M-2.07M2.65M3.16M4.08M4.5M4.73M3.65M3.18M3.34M3.47M3.5M3.39M3M2.49M1.88M890K-1.06M181K
Pretax Income-7.19M-19.88M-21.66M-15.85M-17.94M-18.83M-19.5M-19.12M-22.98M-25.02M-22.12M-13.61M-28.55M-29.93M-28.89M-25.77M-27.31M-26.91M-29.14M-26.08M
Pretax Margin %-44.74%-608.36%-234.28%-194.39%-237.34%-316.43%-682.88%-244.9%-333.61%-495.37%-383.43%-77.85%-509.82%-563.72%-690.39%-388.44%-608.31%-686.58%-4087.38%-63609.76%
Income Tax00000000001.99M738K942K560K000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%-8.98%-5.42%-3.3%-1.87%0%0%0%0%0%0%
Net Income-7.19M-19.88M-21.66M-15.85M-17.94M-18.83M-19.5M-19.12M-22.98M-25.02M-24.11M-14.35M-29.49M-30.49M-28.89M-25.77M-27.31M-26.91M-29.14M-26.08M
Net Margin %-44.74%-608.36%-234.28%-194.39%-237.34%-316.43%-682.88%-244.9%-333.61%-495.37%-417.85%-82.07%-526.65%-574.27%-690.39%-388.44%-608.31%-686.58%-4087.38%-63609.76%
Net Income Growth %59.91%-5.53%-11.08%17.12%21.95%24.71%19.09%-33.3%22.07%17.95%16.55%44.33%-7.96%-13.28%0.88%1.19%-18.18%-17.09%-40.39%-41.99%
Net Income (Continuing)-7.19M-19.88M-21.66M-15.85M-17.94M-18.83M-19.5M-19.12M-22.98M-25.02M-24.11M-14.35M-29.49M-30.49M-28.89M-25.77M-27.31M-26.91M-29.14M-26.08M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.10-0.29-0.35-0.25-0.28-0.30-0.31-0.31-0.45-0.59-0.57-0.34-0.70-0.73-0.82-0.56-0.66-0.634.62-0.71
EPS Growth %64.29%3.33%-12.9%19.35%37.78%49.15%45.61%8.82%35.71%19.18%30.49%39.29%-6.06%-15.87%-117.75%21.13%-4.76%-1.61%--39.22%
EPS (Basic)-0.10-0.29-0.35-0.25-0.28-0.30-0.31-0.31-0.45-0.59-0.57-0.34-0.70-0.73-0.82-0.56-0.66-0.634.62-0.71
Diluted Shares Outstanding70.63M69.54M62.98M63.03M62.98M62.85M62.6M62.6M51.58M42.43M42.28M42.03M41.83M41.81M41.8M41.67M41.52M41.37M36.97M36.97M
Basic Shares Outstanding70.63M69.54M62.98M63.03M62.98M62.85M62.6M62.6M51.58M42.43M42.28M42.03M41.83M41.81M41.8M41.67M41.52M41.37M36.97M36.97M
Dividend Payout Ratio--------------------